FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Catalent's Free Cash Flow for the
three
months ended in Mar. 2024 was $-62 Mil. Catalent's Revenue for the
three
months ended in Mar. 2024 was $1,074 Mil. Therefore, Catalent's FCF Margin % for the quarter that ended in Mar. 2024 was -5.77%.
The historical rank and industry rank for Catalent's FCF Margin % or its related term are showing as below:
CTLT'
s FCF Margin % Range Over the Past 10 Years
Min: -7.55 Med: 1.02 Max: 8.04
Current: -2.97
During the past 13 years, the highest FCF Margin % of Catalent was 8.04%. The lowest was -7.55%. And the median was 1.02%.
CTLT's FCF Margin % is ranked worse than 55.78% of 1029
companies
in the Drug Manufacturers industry
Industry Median: -0.47
vs CTLT: -2.97
Catalent FCF Margin % Historical Data
The historical data trend for Catalent's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Catalent's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Catalent's FCF Margin % Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Catalent's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Catalent's FCF Margin % falls into.
Catalent FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
Catalent's FCF Margin for the fiscal year that ended in Jun. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Catalent FCF Margin % Related Terms
Thank you for viewing the detailed overview of Catalent's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CTLT has been successfully added to your 